Emcure Pharmaceuticals Ltd
Price Range
₹960 - ₹1,008
Min. Quantity
14
Closes on
5 July 2024
Min. investment
₹14,112/196 Shares
Emcure Pharmaceuticals Ltd IPO Timeline
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay. Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001.
| Event | Date |
|---|---|
| Emcure Pharmaceuticals Ltd IPO Opening Date | 3 July 2024 |
| Emcure Pharmaceuticals Ltd IPO Closing Date | 5 July 2024 |
| Basis of Allotment | 8 July 2024 |
| Initiation of Refunds | 9 July 2024 |
| Credit of Shares to Demat | 9 July 2024 |
| Emcure Pharmaceuticals Ltd IPO Listing Date | 10 July 2024 |
Emcure Pharmaceuticals Ltd IPO Details
| Emcure Pharmaceuticals Ltd IPO Date | 3 July 2024 to 5 July 2024 |
| Emcure Pharmaceuticals Ltd IPO Face Value | ₹10 per share |
| Emcure Pharmaceuticals Ltd IPO Price | ₹960 to ₹1008 per share |
| Emcure Pharmaceuticals Ltd IPO Lot Size | 14 |
| Issue Size | Shares of ₹10 (aggregating up to ₹1,952.03 Cr) |
| Fresh Issue | Shares of ₹10 (aggregating up to ₹800 Cr) |
| Offer for Sale | Shares of ₹10 (aggregating up to ₹1,152.03 Cr) |
| Issue Type | (Book Built Portion) |
| Listing At | BSE, NSE |
| QIB Shares Offered | Not more than 37,62,896 of the Net Offer |
| Retail Shares Offered | Not less than 68,82,219 of the Net Offer |
| NII (HNI) Shares Offered | Not less than 29,49,523 of the Net Offer |
| Company Promoters | Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar |
Emcure Pharmaceuticals Ltd IPO Lot Size
The Emcure Pharmaceuticals Ltd IPO lot size is 14 shares. A retail-individual investor can apply for up to 14 lots (196 shares or ₹1,97,568).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 14 | ₹14,112 |
| Maximum | 14 | 196 | ₹1,97,568 |
- Strengths
- Risks
- Opportunities
- Well-placed to leverage leading position in the domestic market.
- Demonstrated capabilities of building brands.
- Large, diversified and fast-growing product portfolio in international markets.
- Strong R&D capabilities driving differentiated portfolio of products.
- Extensive and diversified manufacturing capacity.
- Highly qualified, experienced and entrepreneurial management team and its Board.
Company Financials
Emcure Pharmaceuticals Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2024 | 4,756.93 | 3,635.91 | 160.83 |
| 03-2023 | 4,615.85 | 3,232.43 | 160.06 |
| 03-2022 | 4,323.18 | 3,519.92 | 446.81 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Prepayment or Scheduled Repayment of all or a portion of certain Outstanding Borrowings availed by the Company
- General Corporate Purposes
Emcure Pharmaceuticals Ltd IPO Promoter Holding
| Pre Issue Share Holding | 41.85% |
| Post Issue Share Holding | 39.87% |
Emcure Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)
The Emcure Pharmaceuticals Ltd IPO is subscribed 67.87 times on 5 July 2024 05:00:00 PM. The public issue subscribed 7.21 times in the retail category, 195.83 times in the QIB category, and 48.32 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
| Subscription (times) | 195.83 | 48.32 | 7.21 | 8.81 | 67.87 |
Emcure Pharmaceuticals Ltd IPO Prospectus
Emcure Pharmaceuticals Ltd IPO Listing Date
| Listing Date | 10 July 2024 |
| BSE Script | 544210 |
| NSE Symbol | EMCURE |
| Listing In | BSE, NSE |
| ISIN | INE168P01015 |
| IPO Price | ₹1,008 |
| Face Value | ₹10 |
Company Contact Information
Plot # P-1 & P-2 IT BT ParkPhase II MIDC Hinjawadi,Pune-411057
Phone: +91 20 3507 0033/+91 20 3507 0000
Email: investors@emcure.com
Website: www.emcure.com
Emcure Pharmaceuticals Ltd IPO Registrar
Emcure Pharmaceuticals Ltd IPO Lead Manager(s)
- Axis Capital Ltd
- Kotak Mahindra Capital Company Ltd
- Jefferies India Pvt Ltd
- J.P. Morgan India Pvt Ltd
FAQ
What is the issue size of Emcure Pharmaceuticals Ltd IPO?
I have pre-applied for Emcure Pharmaceuticals Ltd IPO. When will my order get placed?
In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.